Pacific Biosciences Of California PACB
NASDAQ PACB
$1.29 -0.03 (-2.27%)
As of: Sep 9, 2026 · 2:23 PM EDT

Pacific Biosciences Of California (PACB) EPS (Diluted) (2014 - 2026)

Analysis

Pacific Biosciences Of California (PACB) EPS (Diluted) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Thermo Fisher Scientific 224.92 Bn 220.85 Bn 8.34 Bn 4.74
2 Danaher 144.67 Bn 140.33 Bn 3.61 Bn 1.23
3 Agilent Technologies 41.02 Bn 39.26 Bn 1.04 Bn 1.28
4 Illumina 31.29 Bn 30.12 Bn 770.00 Mn 1.35
5 Revvity 13.86 Bn 12.84 Bn 416.87 Mn 0.46
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 0.35
7 Bio-Rad Laboratories 10.12 Bn 8.50 Bn 345.80 Mn 13.85
8 Repligen 9.31 Bn 8.29 Bn 110.04 Mn 0.09
9 10x Genomics 8.66 Bn 8.10 Bn 112.50 Mn -0.14
10 Pacific Biosciences Of California 400.74 Mn 163.87 Mn 12.64 Mn -0.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Mar 31, 2026 -0.03
Dec 31, 2025 -0.13
Sep 30, 2025 -0.13
Jun 30, 2025 -0.14
Mar 31, 2025 -1.44
Dec 31, 2024 0.01
Sep 30, 2024 -0.22
Jun 30, 2024 -0.64
Mar 31, 2024 -0.29
Dec 31, 2023 -0.32
Sep 30, 2023 -0.26
Jun 30, 2023 -0.28
Mar 31, 2023 -0.36
Dec 31, 2022 -0.38
Sep 30, 2022 -0.34
Jun 30, 2022 -0.32
Mar 31, 2022 -0.37
Dec 31, 2021 -0.34
Jun 30, 2021 -0.21